Cerebrospinal fluid 5-hydroxyindoles and behavior after l-tryptophan and pyridoxine administration to psychiatric patients
- 1 November 1970
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 9 (6) , 599-604
- https://doi.org/10.1016/0028-3908(70)90011-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Potentiation of a monoamine oxidase inhibitor by tryptophanJournal of Psychiatric Research, 1969
- Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in psychiatric patientsInternational Journal of Neuropharmacology, 1969
- Decrease of 5-Hydroxytryptamine in the Brain provoked by Hydrocortisone and its Prevention by AllopurinolNature, 1968
- Measurement of acid monoamine metabolites in human and animal cerebrospinal fluidJournal of Neurochemistry, 1968
- COMPARISON OF 5‐HYDROXYINDOLES IN VARIOUS REGIONS OF DOG BRAIN AND CEREBROSPINAL FLUIDJournal of Neurochemistry, 1968
- TRYPTOPHAN IN THE TREATMENT OF DEPRESSIONThe Lancet, 1967
- 5‐HYDROXYINDOLE METABOLISM IN RAT BRAIN. A STUDY OF INTERMEDIATE METABOLISM USING THE TECHNIQUE OF TRYPTOPHAN LOADING–I METHODSJournal of Neurochemistry, 1965
- L-METHIONINE AND L-TRYPTOPHAN FEEDINGS IN NON-PSYCHOTIC AND SCHIZOPHRENIC PATIENTS WITH AND WITHOUT TRANYLCYPROMINEJournal of Nervous & Mental Disease, 1963
- POTENTIATION OF THE ANTIDEPRESSIVE EFFECT OF A MONOAMINE-OXIDASE INHIBITOR BY TRYPTOPHANThe Lancet, 1963
- Observations on Schizophrenic Patients After Iproniazid and TryptophanArchives of Neurology & Psychiatry, 1958